English 
Spanish 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 开放获取期刊获得更多读者和引用
700 种期刊 和 15,000,000 名读者 每份期刊 获得 25,000 多名读者
索引于
- CAS 来源索引 (CASSI)
- 哥白尼索引
- 谷歌学术
- 夏尔巴·罗密欧
- 打开 J 门
- 学术钥匙
- 参考搜索
- 哈姆达大学
- 亚利桑那州EBSCO
- OCLC-世界猫
- 普布隆斯
- 欧洲酒吧
- ICMJE
有用的链接
开放获取期刊
分享此页面
抽象的
Pharmacy on Adult Diabetic Hepatitis B Immunization
Medhane Cumbay
Acute or chronic liver infection brought on by the Hepatitis B virus is known as hepatitis B (HepB) (HBV). 1 The Centers for Disease Control and Prevention (CDC) recorded 3192 cases of acute HBV infection in the United States in 2019. However, the actual number of cases is thought to be 6.5 times higher than the reported cases at any given time, with cases facing a 15–25 percent risk of untimely death from cirrhosis or liver cancer and the actuality of ethnic and ethnic differences in habit frequency. Habitual HBV infection also continues to be a serious public health issue. In response, the Viral Hepatitis National Strategy Plan for the United States 2021–2025 was published by the Department of Health and Human Services (HHS) to eliminate viral hepatitis as a concern.